These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6087713)

  • 1. [Mechanism of action of positive inotropic substances].
    Godfraind T
    Ann Cardiol Angeiol (Paris); 1984; 33(4):197-201. PubMed ID: 6087713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.
    Colucci WS; Wright RF; Braunwald E
    N Engl J Med; 1986 Jan; 314(5):290-9. PubMed ID: 2867470
    [No Abstract]   [Full Text] [Related]  

  • 3. The basic mechanism of inotropic action of digitalis glycosides.
    Smith TW
    J Pharmacol; 1984; 15 Suppl 1():35-51. PubMed ID: 6328127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inotropic drugs and their mechanisms of action.
    Scholz H
    J Am Coll Cardiol; 1984 Aug; 4(2):389-97. PubMed ID: 6330195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of positive inotropic actions based on electrophysiologic characteristics: where should calcium sensitizers be placed?
    Varro A; Papp JG
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S32-44. PubMed ID: 8907129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular mechanisms responsible for the inotropic action of insulin on failing human myocardium.
    Hsu CH; Wei J; Chen YC; Yang SP; Tsai CS; Lin CI
    J Heart Lung Transplant; 2006 Sep; 25(9):1126-34. PubMed ID: 16962476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simulation analysis of intracellular Na+ and Cl- homeostasis during beta 1-adrenergic stimulation of cardiac myocyte.
    Kuzumoto M; Takeuchi A; Nakai H; Oka C; Noma A; Matsuoka S
    Prog Biophys Mol Biol; 2008; 96(1-3):171-86. PubMed ID: 17826821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
    Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of calcium ions and the participation of the mitochondria in realizing the positive inotropic action of cardiac glycosides (a review of the literature)].
    Denisov IuP
    Farmakol Toksikol; 1980; 43(6):740-5. PubMed ID: 6256209
    [No Abstract]   [Full Text] [Related]  

  • 11. [Quantitative aspects of specific binding of cardiac glycosides to membrane receptors].
    Erdmann E
    Fortschr Med; 1979 Jul; 97(25-26):1167-70. PubMed ID: 222657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection.
    Yu QJ; Si R; Zhou N; Zhang HF; Guo WY; Wang HC; Gao F
    Apoptosis; 2008 Feb; 13(2):305-17. PubMed ID: 18165901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and cellular level of action of digitalis.
    Charlemagne D
    Herz; 1993 Apr; 18(2):79-85. PubMed ID: 7684015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
    Erdmann E; Schwinger R; Böhm M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacology of inotropic agents].
    Pastelín Hernández G
    Arch Cardiol Mex; 2002; 72 Suppl 1():S156-62. PubMed ID: 12001837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Direct cardiac mechanism of action of digitalis glycosides].
    Lechat P; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1983 Aug; 76(8):953-8. PubMed ID: 6312915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current concept for the cardiac glycoside receptor.
    Bodemann HH
    Clin Cardiol; 1981; 4(5):223-8. PubMed ID: 6273035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-cyclic AMP-dependent, positive inotropic cyclodepsipeptides with negative chronotropy.
    Tsunoo A; Kamijo M
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1006-12. PubMed ID: 10454471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New inotropic drugs].
    Ferrari M; Cargnelli G; Piovan D; Bova S; Padrini R
    G Ital Cardiol; 1982; 12(2):139-46. PubMed ID: 6293904
    [No Abstract]   [Full Text] [Related]  

  • 20. Digoxin reduces beta-adrenergic contractile response in rabbit hearts. Ca(2+)-dependent inhibition of adenylyl cyclase activity via Na+/Ca2+ exchange.
    Nagai K; Murakami T; Iwase T; Tomita T; Sasayama S
    J Clin Invest; 1996 Jan; 97(1):6-13. PubMed ID: 8550851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.